India rejects application to extend patent on TB drug bedaquiline. Thiagarajan K. BMJ 2023;380:724.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Thiagarajan K. India rejects application to extend patent on TB drug bedaquiline. BMJ 2023;380:724.
PMID: 36977519